The general objective of this study
INTRODUCTION
Neuroimplant is a clinical tool that stimulates the nervous system under the skin following surgery [1] . Neurostimulation is a process by which nerves partially losing their function as a result of disease or trauma are stimulated using artificial electrical pulses for regeneration [2] . Electrical signals used for this purpose must be consistent with the nature of human neurophysiology [3] .
Confusion resulting from chaos in electrical parameters may lead to misuse of otherwise clinically established neurostimulation therapy.
Earlier studies have shown that certain selected parameters play an important role in the safety and efficacy of the therapy for various applications [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Whilst comprehensively considering scientific aspects of stimulation, the recently developed Tulgar neuroimplant system has made possible the opportunity to try parameters which are consistent with the nature of the human body [16] [17] [18] . This study is one of seven steps of a long-term research program related to Tulgar implants: (1) the development of a prototype model; (2) bench testing with the prototype; (3) laboratory tests; (4) environmental safety tests; (5) development of clinical model that is implantable in the living tissue; (6) animal testing [17] ; and (7) pilot implantation in humans. The data presented in the present study covers the human implantation phase.
MATERIALS AND METHODS

Patient Selection
Since 2007, 105 patients (64 males and 41 females) suffering from refractory epilepsy for 3-35 years participated in the study. The patients were aged 5-69 years (mean 28.11 ± 12.90). Eighteen patients were children (14 boys and 4 girls) aged 5-15 years (mean 10.22 ± 3.28). MATLAB 7.5 R2007b (The MathWorks Inc., Natick, MA, USA) was used for statistical procedure.
The subjects were experiencing two or more tonic chronic convulsions a week, in addition to four or more absence seizures a day despite use of four or more anti-epileptic drugs. One patient underwent failed resective epilepsy surgery before this study, with only a 10% benefit in terms of intensity and frequency. All other patients were not indicated for resective surgery. No patients with mental disorders participated in the study. None of the participants had brain tumors.
Implants
Tulgar implants were used after approval by the Ethical Committee of the Ministry of Health of the Republic of Turkey. Technical specifications of the implants are explained elsewhere [17] . The main goal of the Tulgar neuroimplant, which is a semi-implantable system, is that the implanted part is completely passive, containing neither a battery nor any active electronic components.
This allows patients to use such a breakdownfree system for as long as they require it. There is no risk of extra surgery for replacement of the system that may result from electronic failure or a limited battery life. A finger-tip sized external compact stimulator powers and controls the system, and is placed on the skin overlying the implanted passive element. The external unit is recharged by a portable charger every 2 weeks. During recharging, patients can use the spare external unit provided. Programming of the external unit can easily be achieved using a purpose-built software located in a netbook. On the other hand, removal of the battery and active electronic components minimized the size of the passive element (79% reduction in size), making it the smallest implant available at present. The reduction in size facilitates the surgery, particularly in children, and even in infants; however, infants must be 36 months old, following the advice of pediatric neurologists, so that the infant brain can complete its development [19] .
Implantation
As with any vagal stimulation surgery, the left vagus nerve was exposed by removing the carotid sheet, and the nerve was separated below the superior and inferior cervical cardiac branches. A subcutaneous pocket below the clavicle bone in the left side of the chest was also created to house the passive element. The passive element in the chest pocket was secured with its silicone pad facing the skin, and by suturing three points at the Physiological studies have shown that heart rate and breathing frequency change depending on age, sex, and position of the patient, e.g., standing up during daily life and lying down during sleep [19] . Having considered these physiological facts, the authors used eight age groups (4-11, 12-17, 18-25, 26- A total of 29 out of 105 (27.61%) patients reported a reduction in the number of epileptic seizures during the resting period of 2 weeks following the operation and before the stimulation began.
DISCUSSION
Having compared the results of this study with the other similar studies undertaken with nonTulgar implants, there is a dramatic difference.
Similar studies have reported only a 10% full recovery, 60% partial improvement in quality of life, and 30% zero response [21, 22] .
Comparison of these results with those of the present study reveals an approximate fivefold increase in seizure freedom, and a threefold decrease in the number of nonresponsive patients.
There are two main differences between the Tulgar and non-Tulgar devices: (1) construction and (2) The present study addresses the question of whether it is really necessary to modulate the stimulation signals and, if so, how it is achieved? It is known that the brain demodulates the data from the peripheral nerve, detecting the patterns of nerve impulses, and paying particular attention to frequency [23, 24] . Since the language that the brain understands is frequency, it might be worthwhile modifying the patterns of pulses rather than keeping them constant, i.e., the technique used in conventional mode of stimulation. Frequency modulation of the stimulus obviates, at least in part, this phenomenon, and delivers essential novel stimuli to which the nervous system responds without adaptation [25] . Considering the earlier scientific and clinical studies, the designing of patterns of electrical pulses is of particular importance. The human body is an integrated unitary system incorporating synchronized multifunctional sub-systems, with the nervous system coordinating this system. The language of the nervous system should be consistent with the other ongoing activities, such as cardiopulmonary activity. Furthermore, the body's own language also has to be considered when modulating the frequency, as modulation must be combined with other factors, such as heart rate and breathing frequency depending on age and sex, as well as the position of patient (standing up or lying down).
With regards to secondary outcomes, the reduction in epileptic seizures during postoperative resting time experienced by some participants might be explained by a mechanical stimulation effect resulting from the manipulation of the vagus nerve during surgery, and touching of the electrode to the neighboring tissue following surgery.
Furthermore, another outcome of the present study is that, with these dramatic positive changes in the results in mind, improved VNS seems to be more cost-effective versus drug therapy for the management of refractory epilepsy [26] . The authors are, of course, aware that the alternative vagal stimulators have been studied in larger numbers of patients since 1997; however, the 105 patients included in the present study is not a neglectable population.
CONCLUSION
The findings of the present study imply that HBP-modulated mode of stimulation could be safer and more effective in neurostimulation, at least in VNS, and worth applying in extensive studies which include a larger number of patients.
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